The National Institutes of Health (NIH) Office of the Director awarded a $15,083,516 Project Grant under the Construction Support (CFDA 93.352) program to the Trustees of Boston University, doing business as the Boston University Medical Campus. The grant funding will be used to modernize and renovate the National Emerging Infectious Diseases Laboratories (NEIDL) research facilities at Boston University. The key goals are to: 1) Modify the Biosafety Level (BSL)-3 and Animal Biosafety Level (ABSL)-3 spaces to allow for individual room isolation and decontamination while maintaining uninterrupted work in other areas; 2) Renovate the arthropod containment space to expand tick research capacity and enable concurrent mosquito vector studies; and 3) Modernize the BSL-4 air locks to expedite the decontamination process. These upgrades will enhance the NEIDL's operational efficiency, increase research flexibility, and improve turnaround time for essential studies on high-consequence pathogens. The award period runs from September 17, 2024 through May 31, 2029.
Generated 3/4/25, 5:06 AM